Unveiling MRI-based structural phenotypes in temporomandibular joint osteoarthritis: implications for clinical practice and research

ABSTRACT Introduction: Osteoarthritis (OA) is a progressive degenerative disease characterized by the gradual degradation of cartilage, remodeling of subchondral bone, synovitis, and chronic pain. This condition impacts various large and small joints, including the temporomandibular joint (TMJ). However, addressing OA, particularly in impeding or reducing disease progression, is challenging due to its clinical and imaging heterogeneity. Authors are increasingly suggesting that this heterogeneity involves different phenotypes or subpopulations, discernible by variations in the disease’s pathophysiology and structural manifestations. Even within the TMJ, these phenotypes may display distinct clinical features, laboratory parameters, biochemical markers, and imaging criteria. Recent research has proposed MRI as a reference standard for TMJ OA, highlighting its substantial agreement with histopathological changes. MRI-based phenotypes offer a promising avenue for understanding disease progression and treatment response, potentially providing valuable insights for prognosis and treatment planning. Objective: This article introduces the ROAMES-TMJ (Rapid OsteoArthritis MRI Eligibility Score for TMJ) to assess the structural eligibility of individuals for inclusion in TMJ OA clinical trials.


INTRODUCTION
The public health impact of osteoarthritis (OA) is increasingly significant, marked by a rising prevalence that makes it the most common among around a hundred forms of arthritis.This escalating prevalence brings substantial disability and economic burdens. 1 Currently, interventions are limited to exercises, self-management programs, analgesics, and, in cases of severe and unresponsive conditions, more invasive procedures.These secondary approaches may range from minimally invasive intra-articular injections of various medications and biologically active substances to arthroscopic or open surgeries, ultimately leading to total joint replacement. 2ven these challenges, there is an urgent need to deepen our understanding of OA's underlying etiology, identify effective treatments, and establish preventative strategies to alleviate pain and minimize joint damage.
Efforts to address OA, especially in impeding or reducing disease progression, face obstacles due to the heterogeneity of the condition.Formulating a universally applicable therapy for such a diverse and unselected patient population proves to be a daunting task.
Dental Press J Orthod.2024;29(4):e24spe4 OA can stem from various factors, including post-traumatic events, genetic predisposition, metabolic influences, and biomechanical issues. 3Furthermore, the complexity is heightened by the involvement of multiple mechanisms in pain perception associated with OA. 4 Recognizing this heterogeneity, there is a growing consensus that OA is not a singular disease, but rather a syndrome involving the joints as an organ, encompassing multiple distinct phenotypes. 5 a syndrome, OA affects different large and small joints, including the temporomandibular joint (TMJ).While the knee, a large synovial joint, is one of the most frequently affected, with about 14% of the adult US population affected by knee OA, 6 the TMJ experiences a similar incidence of cartilage ailments.However, the knee orthopedics field has greater funding and more effective end-stage treatment options, being considered as a template for the development of TMJ diagnosis and treatment strategies. 7is perspective forms the foundation of this narrative review, which centers on the concept of knee OA phenotypes 8

THE IMPORTANCE OF TMJ OA PHENOTYPES
Pathological changes in OA can manifest in multiple joint tissues, providing a myriad of potential treatment targets.
Given the multifaceted nature of tissue involvement in OA, it is improbable that a singular treatment approach will be universally effective in preventing or slowing the progression of all structural OA types.Authors increasingly propose that OA encompasses various phenotypes or subpopulations, distinguished by the disease's pathophysiology and structural manifestations. 9Even in the TMJ, these phenotypes may exhibit distinct clinical features, laboratory parameters, biochemical markers, and/or imaging criteria. 10aditionally, the TMJ OA field has centered around an articular cartilage disease model.However, the timing and sequence of cartilage erosive changes are still controversial.It is not clear whether the osteoarthritic degenerative disease begins in the superficial or calcified deep layers of the articular cartilage, or even subchondral bone.Thus, more recently, a bone-driven cartilage progression disease model has been proposed. 11wever, inflammation is now acknowledged as a central aspect of OA pathology.While not always the primary initiator, Dental Press J Orthod.2024;29(4):e24spe4 inflammation is present in early OA stages and may become the driver of disease progression. 12e challenges faced by numerous phase II/III OA clinical trials, and the potential failure to translate short-term clinical benefits into real structural improvement may be partly attributed to difficulties in identifying patient subpopulations with structural abnormalities aligning with drug pharmacodynamic.
Understanding OA phenotypes is crucial for developing targeted treatments and assessing the efficacy of disease-modifying osteoarthritis drugs.Current Diagnostic criteria for temporomandibular disorders (DC/TMD) indicates that computed tomography (CT) or cone beam CT (CB-CT) are needed for diagnosis confirmation of OA; 13 however, recent research suggested the MRI as a reference standard for TMJ OA, given its substantial agreement with histopathological changes. 14 this sense, MRI-based phenotypes offer a promising avenue for comprehending disease progression and treatment response, potentially providing prognostic and treatment planning value. 15Synthesis of main clinical and imaging features of each OA phenotype proposed is shown in Table 1.

CARTILAGE EROSIVE PHENOTYPE
While MRI is effective in identifying the cartilage layer in large joints, it faces challenges in accurately detecting degenerative changes in mandibular condylar cartilage due to its extremely thin nature.This distinctive fibrocartilage, which have a thickness of 1.5 to 2 mm in the mandibular condyle and 0.5 to 1 mm in the mandibular fossa, 16 is highly susceptible to the mechanical environment, and overloading can precipitate degenerative changes, which can be reversed by self-repair at early stages. 17us, recognizing the pivotal role of the disc in load distribution and shock absorption for safeguarding cartilage, an erosive cartilage phenotype often presents itself alongside disc displacement and/or damage, leading to widespread cartilage loss.Histological assessments classify cartilage changes into four sub-grades: intact surface, surface discontinuities, vertical fissures, and erosion, based on the depth of the zone (fibrous, proliferative, or hypertrophic) to which the degenerative processes comprise. 14reversible histological damage was found in TMJ disc displacement without reduction.In patients with clinical diagnosis of disc displacement without reduction and limited mandibular opening, about 56% of the TMJ fibrocartilage was absent or only focally present.When diagnosing degenerative joint disease, clinical diagnosis of joint crepitus confirmed by CT images shows a significant increase in these numbers, with total fibrocartilage absence in up to 30% of analyzed joints, and only focal presence in over 50%.In these cases, none of the joints exhibit intact fibrocartilage. 18rtilage loss exposes the subchondral bone through condylar surface, leading to progressive bone erosion (Fig. 1).Therefore, MRI-detected condylar erosion signifies changes in articular cartilage and the adjacent cortical and subcortical bone, correlating with characteristic clinical findings such as pain, joint sounds, and deviating mandibular movement. 19Synovial activation, considered a secondary phenomenon related to cartilage deterioration, leads to joint effusion, demonstrated to be associated with arthralgia. 20While it can be present in cases without arthralgia, its frequency is directly proportional to pain scores, increasing with the intensity of pain. 21hile examining the impact of non-surgical methods on young patients under 18 years, with TMJ-related symptoms, a notable reduction in the proportion of patients with erosive abnormalities was observed.However, despite this improvement, approximately half of these patients were unable to develop an intact cortical outline repair after a median follow-up period of 4 years. 22Further investigation, specifically focusing on asymptomatic patients after conservative treatment, revealed an intriguing natural course during follow-up (mean two years).Most condyles with cortical erosions evolve into an intact and continuous cortex.However, it is crucial to note that in severe TMJ OA, the discontinuous cortex type was found to be unstable, when compared to the continuous cortex type.Condyles exhibiting a discontinuous and hypodense cortex displayed an increased probability of volume reduction over time, 23 which suggests a risk for occlusal changes.

HYPERTROPHIC PHENOTYPE
In the realm of OA, a hypertrophic phenotype is distinguished by the presence and size of osteophytes. 8An osteophyte is a marginal hypertrophy characterized by sclerotic borders and the exophytic angular formation of osseous tissue arising from the surface. 24These fibrocartilage-capped bony outgrowths, originating from the periosteum, contribute to the complexity of OA, through cartilage degradation. 25e pathophysiology of osteophyte formation remains incompletely understood, prompting ongoing research endeavors.
To facilitate systematic investigation, a histological osteophyte classification has been proposed, allowing for the differentiation of four distinct types based on ossification degree and the percentage of mesenchymal connective tissue. 25This classification, established for basic science research questions, demonstrates that osteophyte size and localization are independent of histological stages.Histopathological interpretation of osteophytes in the TMJ is notably lacking in the literature.However, a histopathological examination of TMJ osteophytes revealed fibrocartilaginous core tissue surrounded by bone formation due to dystrophic calcification. 26The relationship between osteophyte formation and cartilage damage is nuanced.While osteophytes can be associated with cartilage damage, they may also occur independently, prompting discussions about whether they  represent a pathological phenomenon or a functional adaptation (Fig. 2).Notably, osteophytes are common in OA and can lead to clinically relevant symptoms, but they can also be present without negative effects. 27stinct periosteal and synovial skeletal progenitors have been identified as contributors to osteophyte formation in OA, suggesting potential targets for disease modification in OA treatment. 28Mechanically-induced osteophytes in the rat knee highlight the role of moderate trauma to the periosteal layer in osteophyte development. 29Furthermore, in TMJ-related studies, a statistically significant association between osteophytes and disc displacement has been observed, especially among cases of disc displacement without reduction. 30A nine-times greater likelihood of osteophyte occurrence was observed in cases of anterior disc displacement without reduction (ADDwoR), whereas a lower OR for their occurrence (OR=2.96)was observed in cases with reduction (ADDwR). 31This underscores the complex interplay between clinical factors, joint changes, and osteophyte development in the TMJ.

BONE PHENOTYPE
The distinctive bone phenotype observed in TMJ OA is char- ill-defined hyperintensity often accompany cartilage damage, playing a crucial role as predictors of subsequent structural progression and symptom fluctuation in TMJ OA.The complex relationship between the BML pattern in the mandibular condyle and TMJ arthralgia is noteworthy.Notably, the resolution of the edema pattern does not consistently correlate with pain reduction and vice versa, 32,33 suggesting that bone marrow no communication with the joint space, 37 and its prevalence strongly predict incident subchondral cysts in the same region, even after adjustment for full-thickness cartilage loss, which supports the bone mechanotransduction theory of subchondral cyst formation. 36These subchondral cyst-like lesions in the TMJ, particularly in the anterosuperior and central parts of the condyle, are more prevalent on TMJ with MRI images of articular DDwoR. 38Despite a tendency for subchondral cysts to naturally resolve over time, the resolution process may manifest as an erosive loss of volume. 39ne sclerosis distribution, characterized by an ill-defined low-signal intensity in the subchondral bone on fluid-sensitive and T1-weighted MRI-images, appears to be ambiguously associated with the presence or absence of erosions. 40It is noteworthy that the presence of baseline MRI-detected subchondral sclerosis does not elevate the risk for subsequent cartilage loss in the same knee region.Despite sharing histological features with edema-like BML and likely being connected to mechanical loading, they may represent distinct phases of changes and remodeling in trabecular bone during the loading process.This could elucidate why cohort studies have not demonstrated an increased risk of longitudinal cartilage loss in the same knee region in the presence of subchondral sclerosis.The intriguing question arises as to whether subchondral sclerosis reflects disease inactivity. 41hus, bone marrow MRI-signal intensity holds the potential to serve as a crucial tool for identifying not only the type of BML present, but also the stage of TMJ OA pathology.Gray matter emerges as a potential reference point for evaluating the signal intensity of bone marrow in the mandibular condyle in the same MRI-sequence. 42A novel diagnostic approach entails the utilization of the signal intensity ratio (SIR) on MRI to quantitatively assess the quality of condylar bone marrow in the TMJ.This noninvasive approach offers valuable insights into personalized and precise treatment strategies for TMJ degenerative disease.A normal SIR appears to be indicative of a healthy condyle, while a higher or lower SIR may serve as an indicator of different stages of TMJ degenerative disease. 43,44 summary, the evolving comprehension of the bone phenotype in TMJ OA encompasses a spectrum of manifestations, including BML ranging from edema-like to sclerosis signals, and subchondral cyst-like lesions.These findings not only enhance our understanding of TMJ pathophysiology but also open novel diagnostic avenues for personalized treatment strategies.

INFLAMMATORY PHENOTYPE
From an MRI perspective, the inflammatory phenotype in TMJ OA is characterized by marked synovitis and/or joint effusion, which typically appears as high signal intensity on T2-weighted MRI (Fig 4).In general OA, synovitis is considered a secondary phenomenon linked to cartilage deterioration, and appears to contribute to the progression of cartilage loss.Arthroscopy evaluations have revealed various synovial abnormalities in TMJ OA, with associations between inflammatory synovitis and progressive cartilage damage. 45wever, although the progression of OA is multifactorial, including biological, mechanical, and psychosocial aspects, a subset of patients shows a dysregulated inflammatory response, characterized by an amplified pro-inflammatory response combined with a lack of attendant anti-inflammatory response.
This phenotype has been observed following different forms of intra-articular lesions.Effusion synovitis is significantly greater in those demonstrating a dysregulated inflammatory response, compared to those with a normal response.Additionally, effusion synovitis correlates significantly with synovial fluid concentrations of degradative enzymes and a biomarker of early cartilage degradation. 46ntra-articular TMD clinical presentation may vary based on the patient's age and mandibular condyle bone maturity, influencing its ability to adapt to overload demands.Particularly, in early ages these disorders can often manifest in a highly inflammatory manner.Identifying TMJ involvement in conditions such as juvenile idiopathic arthritis, idiopathic condylar resorption, and other forms of progressive TMJ destruction in children and  adolescents can be a challenge in the initial stages, leading to diagnostic confusion.It is crucial to note that determining the appropriate treatment pathway relies heavily on identifying the underlying etiology.Although inflammatory findings on gadolinium-enhanced TMJ MRI can provide valuable information, they alone are insufficient for determining the specific etiology of progressive TMJ destruction.In contrast, characteristics of the TMJ disc and its displacement play a significant role and can serve as crucial differentiators between systemic arthritic and non-arthritic etiologies. 47int effusion is often observed in MRI, and its diagnostic value for TMJ arthralgia remains unclear.The mean effusion volume should be greater in patients with TMJ OA and arthralgia, but similar in patients with TMJ OA without arthralgia and control subjects. 20Spontaneous pain appears to align with MRI findings of joint effusion.However, when considering different types of provoked pain, there is a notable distinction.Pain experienced upon palpation of the masticatory muscles and TMJ does not seem to be associated with MRI findings of joint effusion.In contrast, pain triggered by mandibular opening movement does exhibit a correlation with these MRI findings.This suggests that the relationship between pain symptoms and joint effusion may vary depending on the specific type of pain stimulus, emphasizing the need for a nuanced understanding when assessing and interpreting clinical manifestations in TMJ disorders.Future research is needed to determine if non-invasive methods, such as MRI or ultrasonography, can accurately identify patients within this pro-inflammatory phenotype and whether this subset is more prone to rapid changes after injury.

ADAPTIVE PHENOTYPE
A fifth phenotype in adaptive non-osteoarthritic subjects can In the presence of an active inflammatory phenotype in TMJ OA, the preferred approach involves lavage to eliminate primary inflammatory effusion, coupled with the injection of anti-inflammatory drugs like corticosteroids (Fig 5).Arthrocentesis, a minimally invasive procedure for lysis and lavage of the joints, has proven to reduce TMJ arthralgia in the long term, 49 while maintaining similar mandibular function results as those obtained with non-surgical and more conservative approaches. 50A meta-analysis suggested that arthrocentesis performed within three months of conservative treatment might yield additional beneficial results. 51in control during disease flares should primarily be managed with short-term oral NSAIDs, not exceeding one week regime, to mitigate potential severe adverse effects.Ibuprofen was shown to have a significant pain-reducing effect and increased mandibular function.In cases where joint effusion is absent, an assessment of the TMJ OA stage of progress should be conducted.If only cartilage erosion or both cartilage and bone erosion are observed, hyaluronic acid or injectable platelet-rich fibrin should be selected, respectively.If joint effusion is present, the location of the signal on MRI (i.e., in the superior or inferior joint spaces) will determine the space subjected to joint lavage under arthrocentesis.Following superior joint space arthrocentesis, the selection of intra-articular injection therapy will depend on the presence of primary inflammatory effusion (inflammatory phenotype) or secondary inflammatory effusion (other phenotypes), with corticosteroid or hyaluronic acid being chosen, respectively.In cases where joint effusion is observed in the inferior joint spaces of the TMJ, after arthrocentesis, intra-articular therapy should be selected based on the TMJ OA stage of progress, as previously described.When the erosive process initiates and remains at the cartilage level, the primary oral intervention aims at chondroprotection to enhance the self-repair capability of the cartilage.This involves stimulating the proliferation and differentiation of fibrocartilage chondroprogenitors for the formation of new matrix and tissue regeneration. 53Although there is still very low evidence regarding therapeutical effects of glucosamine sulfate on TMJ OA, considering a short-term follow-up (12 weeks), glucosamine was as effective as ibuprofen taken two or three times a day, 54 with the ability to decrease inflammatory biomarkers in synovial fluid. 55The most crucial aspect affecting the clinical efficacy of oral glucosamine in the treatment of TMJ OA was the total administration time.Administration of oral glucosamine for a longer period, i.e., 3 months, led to a significant reduction in TMJ pain and a significant increase in maximum mouth opening. 56 the superficial layers of fibrocartilage interact with synovial fluid, primarily composed of hyaluronic acid (HA), viscosupplementation with HA is recommended following lysis and lavage, to remove reactive inflammatory mediators.An umbrella review revealed a reduction in pain intensity and improvement in functioning among patients affected by intra-articular TMD after HA injections. 57Since this secondary inflammatory process is a consequence of cartilage breakdown, achieving longterm and safe control of the immune reaction to new epitopes, composed of collagen and aggrecan fragments, 58 can be facilitated through drugs employing oral tolerance approaches. 59ese approaches have the potential to be beneficial for both cartilage phenotypes, whether erosive atrophic or hypertrophic, particularly in their early stages.However, to date, there is no clinical evidence of their application in the TMJ.
When tissue damage extends to the subchondral bone, regardless of the primary origin of degenerative processes -whether bone or cartilage erosive phenotypes-, and the loss of fibrocartilage coverage becomes evident, the primary therapeutic focus shifts to bone recorticalization.While the removal of inflammatory mediators is crucial to initiate the self-repair process, promising alternatives involve intra-articular injections of biological products with osteogenic properties, such as platelet concentrates, initially platelet-rich plasma (PRP), 60 and more recently injectable platelet-rich fibrin (i-PRF). 61Although these alternatives have been under investigation in the TMJ OA field for almost a decade, only very recently a clinical trial has tested the efficacy of PRP intra-articular inferior joint space injection, an approach previously used only for hyaluronic acid (HA) or dextrose injections. 62Compared with HA, better results in imaging analysis in the PRP group were obtained. 63In cases where MRI reveals a bone phenotype degenerative process, marked by evident BML but without cortical erosions, controlling the early stages of the process becomes a genuine challenge due to the inaccessibility to the disease niche -the subchondral bone.While attempts to reach the subchondral bone for therapy deposition through intraosseous PRP injections are under investigation in the knee, 64 there is currently a lack of published information regarding similar initiatives in the TMJ.Synthesis of drug therapy proposed to each TMJ OA stage is shown in Table 2.As we embrace these insights, consensus-based definitions and recommendations provide a foundation for future research, emphasizing the integration of clinical, imaging, and biochemical data to refine our understanding and enhance personalized management strategies for TMJ OA.
and underscores the potential significance of defining and understanding structural phenotypes of TMJ OA through imaging.Thus, the purpose of the present article is to introduce, for future validation, the Rapid OsteoArthritis MRI Eligibility Score for TMJ (ROAMES-TMJ), to evaluate the structural eligibility of individuals for inclusion in TMJ OA clinical trials.Through this initial Dental Press J Orthod.2024;29(4):e24spe4 narrative review, we aim to categorize individuals into distinct structural phenotypes, thereby acknowledging the diverse pathological changes associated with TMJ OA.

Figure 1 :
Figure 1: Cartilage erosive phenotype: a loss of continuity of the articular cortex of the condyle can be observed.A) Referential temporomandibular joint MRI sagittal T1-weighted image.B) Temporomandibular joint scheme.Adapted from ROAMES -Rapid OsteoArthritis MRI Eligibility Score (Source: Roemer et al. 8 , 2020).

Tesch 11 Dental
RS, Calcia TBB, De Nordenflycht D -Unveiling MRI-based structural phenotypes in temporomandibular joint osteoarthritis: implications for clinical practice and research

Figure 2 :
Figure 2: Hypertrophic phenotype: a marginal hypertrophy with sclerotic borders and exophytic angular formation of osseous tissue arising from the surface of the condyle (osteophyte) can be observed.A) Referential temporomandibular joint MRI sagittal proton density image.B) Temporomandibular joint scheme.Adapted from ROAMES -Rapid OsteoArthritis MRI Eligibility Score (Source: Roemer et al. 8 , 2020).

Figure 3 :
Figure 3: Bone phenotype: a bone marrow lesion in the condyle, and an irregularly condylar head and/or articular fossa contour.A) Referential temporomandibular joint MRI sagittal T2-weighted image.B) Temporomandibular joint scheme.Adapted from ROAMES -Rapid OsteoArthritis MRI Eligibility Score (Source: Roemer et al. 8 , 2020).A B

Figure 4 :
Figure 4: Inflammatory phenotype: a bright signal inside the joint spaces that has a convex configuration in the anterior and/or posterior recesses, and an irregularly condylar head and/or articular fossa contour.A) Referential temporomandibular joint MRI sagittal T2-weighted image.B) Temporomandibular joint scheme.Adapted from ROAMES -Rapid OsteoArthritis MRI Eligibility Score (Source: Roemer et al. 8 , 2020).

Tesch 20 Dental
RS, Calcia TBB, De Nordenflycht D -Unveiling MRI-based structural phenotypes in temporomandibular joint osteoarthritis: implications for clinical practice and research be identified, comprising individuals with imaging features commonly observed in OA patients, such as flattening and/or subcortical sclerosis.These features are considered indeterminate findings for OA, lacking clinical symptoms or a history indicative of OA.They are typically a normal variation or manifestations of an adaptive response to aging or remodeling due to overload.The presence of this phenotype may not necessitate treatment but rather monitoring, as these imaging features could also serve as precursors to degenerative joint disease. 24INDIVIDUALIZED THERAPEUTIC OPTIONS TMJ OA is recognized as a comprehensive joint pathology, involving processes such as cartilage degradation, synovial inflammation, and bone remodeling.These intricate mechanisms operate at varying intensities during different stages of the disease, and are currently identified as viable therapeutic targets.Despite structural damage affecting all these tissues and perpetuating the active disease state, a predominant focus in clinical trials related to TMJ OA remains on alleviating pain Dental Press J Orthod.2024;29(4):e24spe4 and/or improving mandibular function.Consequently, there exists a notable gap in evidence regarding the regenerative capabilities of the affected tissues.The prevailing challenge is the development of evidence-based personalized treatments tailored to address the diverse needs of these patients.

Figure 5 :
Figure 5:Proposed flow chart for intra-articular injection therapy: Once TMJ OA diagnosis is confirmed, through patient history, physical examination, and MRI images, the presence or absence of joint effusion will determine the need for lavage and anti-inflammatory medications.In cases where joint effusion is absent, an assessment of the TMJ OA stage of progress should be conducted.If only cartilage erosion or both cartilage and bone erosion are observed, hyaluronic acid or injectable platelet-rich fibrin should be selected, respectively.If joint effusion is present, the location of the signal on MRI (i.e., in the superior or inferior joint spaces) will determine the space subjected to joint lavage under arthrocentesis.Following superior joint space arthrocentesis, the selection of intra-articular injection therapy will depend on the presence of primary inflammatory effusion (inflammatory phenotype) or secondary inflammatory effusion (other phenotypes), with corticosteroid or hyaluronic acid being chosen, respectively.In cases where joint effusion is observed in the inferior joint spaces of the TMJ, after arthrocentesis, intra-articular therapy should be selected based on the TMJ OA stage of progress, as previously described.

Table 2 : 27 DentalCONCLUSIONS
Drug therapy proposal according to each TMJ OA stage.I-PRF = injectable platelet rich fibrin; NSAIDs =Non-steroidal anti-inflammatory drugs.FUTURE DIRECTIONSThere is a compelling requirement for consensus-based definitions and recommendations in the realm of OA phenotype research, considering the current knowledge regarding structural phenotypes.The investigation into personalized treatment recommendations for TMJ OA patients is imperative, given the inherent heterogeneity of the disease.The essential exploration of combining clinical, imaging, and biochemical characteristics holds significant promise in refining OA phenotypes.This approach is crucial for fostering a comprehensive understanding and effective management of TMJ OA.Tesch RS, Calcia TBB, De Nordenflycht D -Unveiling MRI-based structural phenotypes in temporomandibular joint osteoarthritis: implications for clinical practice and research In conclusion, the present exploration of MRI-based structural phenotypes in TMJ OA highlights the complexity of the condition.The identification of distinct phenotypes, such as Cartilage Erosive, Hypertrophic, Bone, and Inflammatory Phenotypes, offers valuable insights for personalized therapeutic interventions.Proposed tools like the ROAMES-TMJ (Rapid OsteoArthritis MRI Eligibility Score for TMJ) aim to categorize individuals into specific structural phenotypes, paving the way for tailored treatments.The present findings underscore the need for individualized treatment approaches ranging from very reversible and conservative treatment options to the selective intra-articular injections of different pharmacological or biological products, with anti-inflammatory and/or regenerative properties.

Table 1 :
Main clinical and imaging features of each osteoarthritis phenotype.